Saint Louis University Hospital offers a comprehensive BMT program aimed at long term remission or the cure of the patient’s disease. The BMT program provides an elevated standard of care that involves expert medical staff support, patient education and state of the art technology. Started in 1990, Saint Louis University Hospital in conjunction with SLUCare physicians, have performed hundreds of blood and marrow transplants in patients from the United States, Canada and South America.
Listen to Dr. John Richart about how you can become a donor and save lives. Click here for the KMOV video.
Saint Louis University Hospital with SLUCare physicians performs BMT’s for the following diagnoses:
- AML, ALL, CML and CLL; MDS; Myelofibrosis and myeloproliferative disorders
- Multiple myeloma / amyloidosis, Severe aplastic anemia
- Hodgkinds disease, NHL
- Testicular
- Renal cell, selected brain tumors and sarcomas
Autologous, allogeneic and syngeneic transplants are offered at Saint Louis University Hospital.
Types of allogeneic BMT’s offered are:
- Related: HLA (human leukocyte antigen) matched and mismatched
- Unrelated: HLA matched and mismatched
- Umbilical Cord Blood:
- Single and double,
- HLA matched and mismatched
- Haploidentical
Preparative Regimens offered are:
- Myeloablative
- Nonmyeloablative
- Reduced intensity
Saint Louis University Hospital is committed to treating BMT with a comprehensive approach to care.
The advantages of the BMT program include:
- Team approach to care
- Empowering the patient to take an active role while developing personalized treatment plans
- Social, emotional and spiritual support along the entire continuum of care
- Access to clinical trials including:
- SWOG (Southwest Oncology Group)
- SLU physician investigator trials
- The oncology nursing floor consistently ears the ‘five star award’ for exceptional nursing care. This award is dependent on patient satisfaction surveys.